What Is the Current State of Mental Health in the US Workforce?

June 30, 2020


On this episode of Managed Care Cast, we speak with Michael Thompson, president and chief executive officer (CEO) of the National Alliance of Healthcare Purchaser Coalitions, and Louis Gagnon, CEO of Total Brain, on their findings and how employers can optimize how they monitor and support mental health in their respective workforce.

Gilead Sciences Sets US Price for COVID-19 Drug at $2340 to $3120 Based on Insurance

June 29, 2020


In the United States, Gilead Sciences set the price for remdesivir, its antiviral drug that can shorten hospitalization stays for individuals ill with coronavirus disease 2019 (COVID-19), based on insurance factors, and is allowing generic drug makers to create the drug for less in low to middle income countries.

Humana CEO Says Health Care Will Never Be the Same, Here's Why He's Right

June 28, 2020


Rita E. Numerof, PhD, is the president of Numerof & Associates, a firm that helps businesses across the healthcare sector define and implement strategies for winning in dynamic markets. For more than 25 years, she has helped executives understand the implications of an evolving healthcare market. Working with leaders in the healthcare space, she has consulted with everyone from top academic and community hospital systems, payers, and Fortune 500 pharmaceutical, device, and diagnostics companies. She is the coauthor of several books, most recently, "Bringing Value to Healthcare: Practical Steps for Getting to a Market-Based Model" (2016).

PwC Provides 3 Spending Scenarios to Address Implications of COVID-19 on the 2021 Medical Cost Trend

June 24, 2020


With the growing uncertainty of the coronavirus disease 2019 (COVID-19) pandemic and the emergence of services such as telehealth and behavioral health, PwC's Health Research Institute provided 3 spending scenarios for employers managing the insurance market. It projects a 4% to 10% increase in the medical cost trend for 2021 based on these scenarios, said Ben Isgur, MPA, Health Research Institute leader at PwC.

Panelists Discuss How Data Partnerships Can Reduce Barriers to Access, Improve Outcomes in Health Care

June 21, 2020


Presented at AHIP’s Institute & Expo Online 2020, panelists discuss in a webinar how greater collaboration of health insurance providers with state and county leaders can ameliorate barriers to access to health care and promote timely interventions to improve health outcomes.

How Can Data Analytics Drive Better Health?

June 18, 2020


In a webinar presented at the AHIP Institute & Online Expo 2020, experts discussed how data analytics are addressing gaps in health care and providing timely, effective interventions.

How Will the COVID-19 Pandemic Affect the Health Insurance Industry?

June 17, 2020


Accelerating the shift to value-based care, as well as the growing presence of telehealth, may be potentially beneficial long-term effects of COVID-19 on the health care industry, said Dan Mendelson, MPP, founder of Avalere Health.

Analyzing the Individual Marketplace for Health Benefits Amid COVID-19

June 16, 2020


On this episode of Managed Care Cast, we speak with John Barkett, MBA, senior director of Policy Affairs in Benefits Delivery and Administration for Willis Towers Watson, on the current outlook of individual markets in private exchange solutions amid the pandemic.

Optimizing Care Delivery Amid COVID-19: A Detailed Report on Current Trends, Responses in US Health Care

June 10, 2020


A report by Innovaccer, titled “COVID-19: What It Means to American Healthcare: Trends, Impacts, Predictions, and the Road Ahead,” details implications of the pandemic for the US health care system, with additional recommendations on how to optimize emerging services such as telehealth.